InsidersTradesSigma
Track the 메쥬 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 메쥬 has recorded 6 insider filings. Market capitalisation: €102.4bn. The latest transaction was reported on 10 April 2026 (Purchase). Among the most active insiders: 박정환. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
메쥬 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and commercialization of pharmaceutical products.